Ketosis-prone type 2 diabetes: Time to revise the classification of diabetes

Diabetes Care

Volumn 29, Issue 12, 2006, Pages 2755-2757

  Umpierrez, Guillermo E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FUNCTION; DIABETIC KETOACIDOSIS; DIAGNOSTIC TEST; EDITORIAL; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; WORLD HEALTH ORGANIZATION;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 33845481653     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1870     Document Type: Editorial

References (43)

1. Fishbein HA, Palumbo PJ: Acute metabolic complications in Diabetes. In Diabetes in America. National Diabetes Data Group, National Institutes of Health, 1995, p. 283-291 (NIH publ. no. 95-1468).
2. Smith CP, Firth D, Bennett S, Howard C, Chisholm P: Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr 87:537-541, 1998
3. Faich GA, Fishbein HA, Ellis SE: The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 117:551-558, 1983
4. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE: Hyperglycemic crises in urban blacks. Arch Intern Med 157:669-675, 1997
5. Type 2 diabetes in children and adolescents: American Diabetes Association. Pediatrics 105:671-680, 2000
6. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE: Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22:1517-1523, 1999
7. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795, 1995
8. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF: Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance. Diabetes 53:645-653, 2004
9. Umpierrez GE, Smiley D, Kitabchi AE: Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 144:350-357, 2006
10. Umpierrez GE, Clark WS, Steen MT: Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care 20:479-483, 1997
11. Banerji MA, Chaiken RL, Lebovitz HE: Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes 45:337-341, 1996
12. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A: Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090-5098, 2003
13. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF: Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabete Metab 28:5-12, 2002
14. Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H, Mbanya JC, Gautier JF: Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 19:832-835, 2002
15. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 43: 741-745, 1994
16. Kitabchi AE: Ketosis-prone diabetes: a new subgroup of patients with atypical type 1 and type 2 diabetes? J Clin Endocrinol Metab 88:5087-5089, 2003
17. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V: New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 159:2317-2322, 1999
18. Yamada K, Nonaka K: Diabetic ketoacidosis in young obese Japanese men (Letter). Diabetes Care 19:671, 1996
19. Balasubramanyam A, Garza G, Rodriquez LVN, Hampe CS, Gaur L, Lernmark Å, Maldonado MR: Accuracy and predictive value of classification schemes for ketosisprone diabetes. Diabetes Care 29:2575-2579, 2006
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (Suppl. 1):S5-S20, 2003
21. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K: Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type I diabetes. Diabetes 36:510-517, 1987
22. Kobayashi T, Nakanishi K, Murase T, Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622-626,1996
23. Schiel R, Muller UA: GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33-40, 2000
24. Pozzilli P, Di Mario U: Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24: 1460-1467, 2001
25. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
26. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
27. Zimmet P, Turner R, McCarty D, Rowley M, Mackay I: Crucial points at diagnosis: type 2 diabetes or slow type 1 diabetes. Diabetes Care 22 (Suppl. 2):B59-B64, 1999
28. Kobayashi T: Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM: the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24 (Suppl.):S95-S99, 1994
29. Borg H, Gottsater A, Fernlund P, Sundkvist G: A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754-1762, 2002
30. Robertson RP, Olson LK, Zhang HJ: Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43:1085-1089, 1994
31. Kahn SE: Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058, 2001
32. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
33. Leahy JL: Natural history of β-cell dysfunction in NIDDM. Diabetes Care 13: 992-1010, 1990
34. Maldonado MR, Otiniano ME, Lee R, Rodriguez L, Balasubramanyam A: Characteristics of ketosis-prone diabetes in a multiethnic indigent community. Ethn Dis 14:243-249, 2004
35. Tan KC, Mackay IR, Zimmet PZ, Hawkins BR, Lam KS: Metabolic and immunologic features of Chinese patients with atypical diabetes. Diabetes Care 23:335-338, 2000
36. McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA: Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med 18:10-16, 2001
37. Aguilera E, Casamitjana R, Ercilla G, Oriola J, Gomis R, Conget I: Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care 27:1108-1114, 2004
38. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance: National Diabetes Data Group. Diabetes 28:1039-1057, 1979
39. World Health Organization Expert Committee on Diabetes Mellitus: Report of a WHO Study Group. 2nd report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
40. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
41. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
42. Banerji MA, Lebovitz HE: Remission in non-insulin-dependent diabetes mellitus: clinical characteristics of remission and relapse in black patients. Medicine 69: 176-185, 1990
43. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P: Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 24:1014-1018, 2001